Amgen, Inc.

Biotech company commences exchange offer for notes due 2032

Published in Health Risk Factor Week, May 3rd, 2005

Amgen, Inc., (AMGN) announced that it has commenced an exchange offer under which Amgen is offering to exchange new Zero Coupon Convertible Notes due 2032 for all of its $2,359,102,000 principal amount at maturity of currently outstanding Liquid Yield Option Notes due 2032.

As consideration for exchanging the old notes for the new notes, holders exchanging old notes will receive an exchange fee of $2.50 per $1,000 principal amount at maturity of the old notes exchanged. The exchange fee will be payable to such holders of old notes on the exchange date, which will be promptly after the expiration date.

Among its features, the new notes are convertible...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Risk Factor Week

Source: Health Risk Factor Week (2005-05-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry